Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference17 articles.
1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.
2. Waarts MR, Stonestrom AJ, Park YC, Levine RL. Targeting mutations in cancer. J Clin Invest. 2022;132(8): e154943. https://doi.org/10.1172/JCI154943.
3. National Comprehensive Cancer Network. Guideline: non-small cell lung cancer. Version 3.2023 April 13, 2023. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
4. Freedman AN, Klabunde CN, Wiant K, Enewold L, Gray SW, Filipski KK, et al. Use of next-generation sequencing tests to guide cancer treatment: results from a nationally representative survey of oncologists in the United States. JCO Precis Oncol. 2018. https://doi.org/10.1200/PO.18.00169.
5. Lemery S, Fashoyin-Aje L, Marcus L, Casak S, Schneider J, Theoret M, et al. Development of tissue-agnostic treatments for patients with cancer. Annu Rev Cancer Biol. 2022;6(1):147–65.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tissue-Agnostic Cancer Therapy Approvals;Surgical Oncology Clinics of North America;2023-12